CAR T cell therapy for pediatric brain cancer warrants further study
This study shows that this therapy can effectively get to the tumor, and the addition of C7R safely augments antitumor activity.
Read MoreThis study shows that this therapy can effectively get to the tumor, and the addition of C7R safely augments antitumor activity.
Read MoreThe findings support further assessing this approach to treat aggressive blood cancers and ultimately improve outcomes in patients.
Read MoreBaylor College of Medicine researchers extend the life and effectiveness of off-the-shelf, cancer-fighting immune T cells.
Read MoreSince he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read More